Immunomedics, Inc.

NASDAQ: IMMU
$33.42
+$0.00 (+0.0%)
Closing price June 2, 2020
The top analyst upgrades, downgrades and initiations seen on Thursday morning include American Express, Encana, Petrobras, Raytheon, Tesla and Walgreens.
Jon C. Ogg
Shares of Immunomedics dropped sharply on Wednesday after the company announced the pricing of its secondary offering.
Chris Lange
Biotech companies that lost their way last week truly burned shareholders, whether it was due to ASCO, earnings or even unfavorable clinical trial updates.
Chris Lange
Some call the ASCO annual meeting the "Super Bowl for biotechs" because of the significance it holds for so many companies.
Chris Lange
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to June 7 in Chicago.
Chris Lange
the top analyst upgrades, downgrades and initiations seen on Friday morning include Activision Blizzard, Berkshire Hathaway, FireEye, Immunomedics, Square, SunPower, Weatherford International,...
Jon C. Ogg
Friday's top analyst upgrades, downgrades and initiations include Ambarella, GoPro, LinkedIn, Mattel, Marriott, Qualcomm and Symantec.
Jon C. Ogg
Source: Jon OggStocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday’s rally was yet another instance where investors proved that they want to buy...
Jon C. Ogg
Source: ThinkstockBelgian pharmaceutical group UCB announced Tuesday morning that its phase 3 trial for lupus treatment epratuzumab failed to produce statistically significant results in both dosages...
Chris Lange
24/7 Wall St. has taken a look at some of the major ASCO winners over the past week and how they have performed since before the ASCO news.
Chris Lange
24/7 Wall St. has taken a look at a few of the major ASCO winners so far. Color and background information has also been added on each, as well as how shares have been moving and the consensus price...
Chris Lange
Investors and traders alike need to keep in mind that low-priced and small-cap stocks almost always come with more implied risks than well-established blue chips.
Jon C. Ogg
Immunomedics may be poised to make big moves going forward in 2015, according to Wells Fargo.
Chris Lange
After Immunomedics announced that it had appointed a new chief medical officer, Wells Fargo issued an analyst call implying upside of over 50%.
Chris Lange
Wednesday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include ADP, Cigna, First Solar, Garmin, LINN Energy and Synchrony.
Jon C. Ogg